Nawal Ouzren is the founder of Sensorion. Sensorion has raised $116M in total funding. Latest round: Growth. Backed by Sanofi, Redmile Group, Artal.
Nawal Ouzren is the former CEO of Sensorion, a clinical-stage biotech company focused on developing therapies for hearing loss disorders. She led the company through a €60 million capital increase in January 2026 before stepping down for personal reasons shortly after the funding announcement.
Full founder directory · Investor directory · Company funding database · Fundraising library